Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

Summary

This study aims to determine the effectiveness of prophylactic antibiotic use for TACE and occurrence of postoperative liver abscess. There would be two comparison groups. Current standard of care treatment at PKLI\&RC (as per local guidelines) would be given to all patients receiving TACE for the intervention group or 'antibiotic group' (i.e., Inj. Ceftriaxone 1g, intravenous × stat). While no antibiotic would be given to the 'no antibiotic group'.

Timeline

Start

2022-11-26

Primary completion

2023-11-26

Completion

2023-12-26

Drugs

Indications

No indication recorded.